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Abstract
Genome-wide association studies are widely used today to discover genetic factors that modify the
risk of complex diseases. Usually, these methods work in a SNP-by-SNP fashion. We present a
gene-based test that can be applied in the context of genome-wide association studies. We
compare both strategies, SNP-based and gene-based, in a sample of cases and controls for
rheumatoid arthritis.
We obtained different results using each strategy. The SNP-based test found the PTPN22 gene
while the gene-based test found the PHF19-TRAF1-C5 region. That suggests that no single strategy
performs better than another in all cases and that a certain underlying genetic architecture can be
delineated more easily with one strategy rather than with another.
Introduction
The last three years have witnessed an enormous increase
in genome-wide association studies (GWAS). The origi-
nal idea behind these studies is to genotype some
hundreds of thousands of single-nucleotide polymorph-
isms (SNP) in a sample of cases and controls for a given
disease, and then look for association between every SNP
and the disease. Thus, the researcher has to perform as
many statistical tests as SNPs that he has. In other words,
the unit of association is the SNP. In this paper, we
propose a statistical test for GWAS in which the basic
unit of association is the gene–that is, the researcher
performs one statistical test per gene. The idea is to
combine the genetic information given by all the SNPs in
a gene to obtain a more informative result.
Our test presents two advantages compared with the
classical SNP-based test. On the one hand, it suffers
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we are doing around 20,000 tests instead of half a
million. On the other hand, we expect that in those
genes with multiple functional variants, the gene-based
test will be more powerful than the SNP-based test [1].
However, the gene-based test presents some drawbacks.
Because genes do not cover the whole genome, the gene-
based test does not use all of the SNPs available.
Moreover, the gene-based test is not as simple as the
SNP-based test and therefore it requires more computa-
tional resources. Our goal was to compare the results
using a SNP-based test to those obtained using a new
gene-based test for GWAS.
To perform the comparison, we used data from
individuals with and without rheumatoid arthritis
(RA)–a systemic autoimmune disease characterized by
inflammation of the synovial tissue and local articular
damage. Studies of RA heritability in two European
populations reported that 60% of the disease variance
can be attributed to genetic factors [2]. Linkage and
association studies have demonstrated that alleles at the
human leukocyte antigen (HLA) class II gene DRB1 have
a strong effect on the risk of RA [3]. However, these
variants do not explain all of the heritability. It is
possible that loci not linked to the HLA region play an
important role in RA susceptibility. Several studies have
reported genes or genomic regions related to RA
susceptibility outside the HLA region [4-8].
Methods
The data
We used the subset of the data from the North American
Rheumatoid Arthritis Consortium (NARAC) study pro-
vided for Genetic Analysis Workshop 16 [9]. It consisted
of 868 cases and 1194 controls. The Ilumina 550 k chip
(545,080 SNPs) was genotyped in the whole sample.
Before the analysis, we cleaned the data. For example, we
excluded SNPs with a call rate smaller than 0.95 (18,627
SNPs), minor allele frequency smaller than 0.01 (23,047
SNPs), or with a p-value for the Hardy-Weingberg
equilibrium test smaller than 1 × 10
-5 (1,342 SNPs).
We also excluded six individuals with sex genotype
inconsistencies. All of the individuals had a call rate
greater than 0.95. All of our analyses were done with
‘affection status’ as the trait of interest and ‘sex’ as a
covariate.
SNP-based test
We estimated the association between the trait RA and a
SNP using logistic regression assuming a codominant
model for the genetic effect of every SNP. We used the
p-value of the test as a measure of statistical significance.
We used the GenABEL software package [10].
Gene-based test
To perform a gene-based test, the first problem is to
define the genes and to assign SNPs to the genes. Also, it
is important to be sure that the physical positions of the
genes and SNPs refer to the same annotation release. We
used the NCBI build 129 release 36.3 for both genes and
SNPs. We accepted that a SNP was in a gene if it was
inside the gene plus or minus 5,000 base pairs. We
analyzed 21,672 genes that contained 272,604 SNPs.
That means that around half of the available SNPs were
not assigned to genes and, thus, they were left out of the
gene-based analysis.
The paradigm for the proposed gene-based test has three
steps [11]:
1. Estimate the genetic similarity among individuals
based on the genotypes of the SNPs in a given gene.
2. Cluster the individuals in groups by genetic similarity.
3. Test the association between the groups of individuals
and the trait of interest.
In the first step, we used the Gower distance. Also known
as Gower’s coefficient [12], it is a measure of the
similarity between two individuals based on the infor-
mation given by a set of quantitative or qualitative
variables. We realized that, in the special case of SNP
genotypes, Gower distance is the same as the identity-by-
state (IBS) multilocus measure. IBS allele sharing is a
measure of genetic similarity between two individuals.
Given the genotypes of two individuals at a given SNP,
the IBS between them is 0, 1, or 2 depending on whether
they share 0, 1, or 2 alleles at that SNP. This measure can
be extended to several SNPs by adding the IBS for each
locus and dividing by twice the number of loci [13]:
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is the IBS between i and j at locus l. We estimated this
similarity measure for every pair of individuals at every
gene. Thus, the result of the first step is a distance matrix
among individuals in a given gene.
In the second step, the distance matrix is used for finding
groups of individuals with similar genotypic distribution
in the given gene. This clustering is performed in a
hierarchical procedure by means of a complete linkage
agglomerative algorithm. Complete linkage evaluates
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most distant pair of individuals. We divided the
individuals in three groups of similarity. To test the
effect of the chosen cluster algorithm on the results, we
repeated the analysis in chromosomes 1, 6, and 9 using
two other cluster algorithms: hierarchical average linkage
agglomerative algorithm and spectral clustering. Average
linkage evaluates distances between two groups as the
mean distance between individuals of each cluster.
Spectral clustering is a method that defines k clusters on
as e to fn data points representing arbitrary objects. It is
based on the spectral decomposition of the normalized
Laplacian graph defined from a similarity matrix among
the objects [14]. In our case, the objects are the
individuals and the similarity matrix is the genetic
similarity matrix defined above.
Finally, in the third step, association between the groups
of individuals and the phenotype of interest was
estimated using logistic regression with the group as a
factor.
Results
SNP-based association
With 545,080 SNPs, the strict Bonferroni p-value for a
genome-wide significance of 0.05 for the SNP-based test
is p =9 . 1 7×1 0
-8. However, because there is some
amount of linkage disequilibrium among them, the
effective number of tests is smaller. A recent study has
estimated that the number of effective independent tests
done with the Illumina 550 k chip is 324,559 [15]. That
means that the adjusted critical p-value is 1.5 × 10
-7.A s
expected, there are many SNPs showing statistically
significant association with RA in chromosome 6.
Specifically, there are 213 statistically significant SNPs,
that cover 74 genes, all of them in the HLA region, in
6p21. In addition, the SNP rs2476601 in chromosome 1
has a p- v a l u eo f2 . 0 4×1 0
-8. This SNP lies on the PTPN22
gene, which has been previously associated with RA [4].
Gene-based association
With 21,672 genes analyzed, the strict Bonferroni p-value
for a genome-wide significance of 0.05 for the gene-
based test is p =2 . 3×1 0
-6. The gene-based association
test presents 60 statistically significant hits, with p-values
a sl o wa s1×1 0
-74, in 6p21, as expected. The number of
SNPs in these genes ranges from 2 to 37, with an average
of 7.7. Table 1 shows the top gene-based association
results outside of chromosome 6.
The PHF19 gene lies in 9q33.2–an area that has been
associated recently with RA [5,8], and shows a clear
statistical significance with the gene-based test, but not
with the SNP-based test. Three other areas that show
suggestive association with RA are 16p13.12, 12q12, and
3p25. These areas contain previously described quanti-
tative-trait loci for RA, which can be found at the UCSC
genome browser database [16].
To test the sensitivity of the new method to the cluster
algorithm, we repeated the analysis of chromosomes 1,
6, and 9 using two other cluster algorithms: hierarchical
agglomerative average algorithm and spectral clustering.
In the HLA region, the average clustering found 42 of the
60 genes found by the original cluster method and 12
genes not detected by the original. On the other hand,
the spectral clustering found 54 of the 60 genes found
also by the original cluster method and 28 not detected
b yt h eo r i g i n a l .O u t s i d eo ft h eH L Ar e g i o n ,t h eg e n e
PHF19 on chromosome 9 was found by the spectral, but
not by the hierarchical average algorithm. None of the
cluster algorithms found the PTPN22 gene that was
found by the SNP-based test.
A possible question associated with the new method is
whether it is sensitive to the number of SNPs in the gene.
We discretized the number of SNPs in quartiles and
tested the association between this variable and the
-log10 of the p-value by means of a one-way ANOVA. We
did not find an association between the two variables
(p = 0.14). We repeated the analysis for each chromo-
some separately and none of them gave a statistically
significant association.
Discussion
We have compared the results of a new gene-based test
with the results using a standard SNP-based test in a
sample of cases and controls for RA in a GWAS. The
procedure of the test was to group the individuals by
Table 1: Gene-based association results out of chromosome 6
Symbol Map location No. SNPs analyzed
on gene
p-Value of the gene-based
test for the gene
Minimum p-value obtained for any SNP
on the gene using the SNP-based test
PTPN22 1p13 6 0,11 2.04 × 10
-8
PHF19 9q33.2 4 9.61 × 10
-7 7.07 × 10
-6
FLJ11151 16p13.12 40 3.98 × 10
-6 2.69 × 10
-4
GLT8D3 12q12 6 8.37 × 10
-6 4.92 × 10
-2
LSM3 3p25.1 5 1.24 × 10
-5 2.31 × 10
-4
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distribution of groups is different between the cases and
the controls. In some ways, this approach is related to the
association with haplotypes, because both approaches
combine genetic information from several SNPs. How-
ever, haplotype-based methods suffer from a statistical
problem–that is, the abundance of rare haplotypes. To
solve this problem, different strategies that reduce the
number of haplotypes have been proposed, i.e., haplo-
type clustering [17] or inference of ancestral haplotypes
[18]. Our approach shares this idea, but is much simpler
because it works directly with genotypes instead of
haplotypes. In fact, in a previous study, we used this
approach with data of a complete resequenced gene and
we were able to group the individuals in the same way
that when using the ancestral haplotypes [11].
As expected, both gene-based and SNP-based tests gave
many statistically significant results in the HLA region.
However, both tests gave different results outside of the
HLA region. The SNP-based test found the PTPN22 gene
while the gene-based test found the PHF19 gene. A
possible explanation is that different underlying genetic
architectures can be more easily detected with one
strategy but not with the other.
The gene-based test has some limitations. One of these
limitations is that, as defined here, it uses only half of
the genetic information available. That is a consequence
of how we assign SNPs to a gene: a SNPs belongs to a
gene if it is inside the gene plus or minus 5,000 base
pairs. Some researchers solve this problem assigning
every SNP to the nearest gene, no matter how far it is
from the gene. We think that a better strategy is to
change the gene-based test to a region-based test. In our
test, we used the gene as the unit of the analysis, but a
genomic region of a fixed size could be used instead.
Then, the test could be applied with a ‘sliding window’
strategy and utilize all the available genetic information.
Other limitations are related to the clustering algorithm.
On the one hand, different algorithms can give slightly
different results and, on the other hand, the test does not
take into account the uncertainty of the clustering
process. To measure and, eventually, correct this bias,
we are planning to evaluate the effects of using different
cluster algorithms and to use re-sampling techniques, as
bootstrap or permutations, to estimate the statistical
evidence of the test.
Conclusion
We performed a GWAS for RA affected status first with a
standard SNP-based association test and second with
a new gene-based association test. Both strategies gave a
large amount of statistical evidence of association in
6p21 and little evidence outside of this region. With the
SNP-based test we found a SNP in the PTPN22 gene that
was not found with the gene-based approach. On the
other hand, with the gene-based test we found an area in
9q33.2 that was not detected by the SNP-based test. We
do not think that one test is better than the other. They
simply use the genetic information in a different way. We
consider both tests as complementary.
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